Coyotebio Lab is a healthcare startup founded in 2015 that specializes in medical diagnostics with a focus on personalized healthcare, tumors, and infectious diseases. Their mission is to deliver swift, non-invasive molecular diagnostic services and ensure comprehensive care through integrated diagnosis and treatment options. The company operates in the Education and Health Care industries. In their latest fundraising efforts, the company completed a Seed Round on 25 April 2018 with investments from Frees Fund and Longly Capital. With a strong focus on cutting-edge diagnostics and personalized healthcare, Coyotebio Lab presents an exciting opportunity for venture capital investors in the health and biotech sectors.
No recent news or press coverage available for Coyotebio-Lab.